Bath & Body Works, Inc. BBWI
- Market cap
- $3.4B
- P/E
- 4.3×
Follow BBWI
Target Price Range
Analyst price targets
Free account| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.29 | 19.17 | 12.77 | 6.47 | 29.18 | 25.75 | 27.30 | 26.21 | 14.28 | 15.74 |
Analyst estimates 2027–2029 Powerpack |
Low Price
|
||
| 55.33 | 49.67 | 24.00 | 34.09 | 82.00 | 71.51 | 49.55 | 52.99 | 41.87 | 24.94 |
High Price
|
|||
| 93,600 | 93,200 | 88,900 | 94,400 | 92,300 | 56,900 | 57,200 | 57,157 | 59,210 | 60,735 |
Employees
|
|||
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| 12,574 | 12,632 | 13,237 | 5,405 | 6,434 | 7,882 | 7,560 | 7,429 | 7,307 | 7,291 |
Revenue
|
|||
| 40.76% | 39.26% | 37.01% | 44.16% | 48.12% | 48.91% | 43.06% | 43.56% | 44.26% | 43.74% |
Gross Margin
|
|||
| 1,696 | 1,312 | 857 | 608 | 1,122 | 1,423 | 1,045 | 1,021 | 1,028 | 882 |
EBT
|
|||
| 13.49% | 10.39% | 6.47% | 11.25% | 17.44% | 18.05% | 13.82% | 13.74% | 14.07% | 12.10% |
EBT Margin
|
|||
| 1,158 | 983 | 644 | (366) | 844 | 1,333 | 800 | 878 | 798 | 649 |
Net Income
|
|||
| 472 | 524 | 547 | 1,308 | 521 | 363 | 221 | 269 | 282 | 254 |
Depreciation
|
|||
| 43.81 | 44.48 | 47.96 | 19.58 | 23.14 | 29.30 | 32.59 | 32.58 | 33.21 | 35.05 |
Revenue/Sh
|
|||
| 3.98 | 3.42 | 2.31 | (1.33) | 3.00 | 4.88 | 3.43 | 3.84 | 3.61 | 3.11 |
Earnings/Sh
|
|||
| 6.93 | 4.95 | 4.99 | 4.48 | 7.33 | 5.55 | 4.93 | 4.18 | 4.03 | 5.30 |
Cash Flow/Sh
|
|||
| (3.26) | (2.49) | (2.28) | (1.66) | (0.82) | (1.00) | (1.41) | (1.31) | (1.03) | (1.10) |
Capex/Sh
|
|||
| 3.67 | 2.46 | 2.71 | 2.82 | 6.51 | 4.54 | 3.52 | 2.88 | 3.00 | 4.20 |
Free CF/Sh
|
|||
| (2.53) | (2.64) | (3.13) | (5.42) | (2.38) | (5.64) | (9.50) | (7.13) | (6.29) | (6.15) |
Book Value/Sh
|
|||
| 287 | 284 | 276 | 276 | 278 | 269 | 232 | 228 | 220 | 208 |
Shares
|
|||
| 12.20 | 11.77 | 9.74 | 0.00 | 11.47 | 10.74 | 13.34 | 11.08 | 10.33 | 7.06 |
PE Ratio
|
|||
| 1.11 | 0.91 | 0.47 | 0.40 | 1.14 | 1.55 | 1.41 | 1.31 | 1.13 | 0.63 |
PS Ratio
|
|||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| 1.41 | 1.25 | 0.80 | 0.71 | 1.55 | 1.88 | 1.92 | 1.78 | 1.61 | 1.04 |
EV/Sales
|
|||
| 16.88 | 22.57 | 14.19 | 11.86 | 7.18 | 14.45 | 17.75 | 20.16 | 17.88 | 8.66 |
EV/FCF
|
|||
| 1,990 | 1,406 | 1,377 | 1,236 | 2,039 | 1,492 | 1,144 | 954 | 886 | 1,102 |
Op' Cash Flow
|
|||
| (937) | (707) | (629) | (458) | (228) | (270) | (328) | (298) | (226) | (228) |
Capex
|
|||
| 1,053 | 699 | 748 | 778 | 1,811 | 1,222 | 816 | 656 | 660 | 874 |
FCF
|
|||
| 1,451 | 1,262 | 1,274 | 873 | 2,753 | 1,719 | 887 | 826 | 592 | 428 |
Working Cap'
|
|||
| 5,736 | 5,794 | 5,811 | 5,548 | 6,539 | 5,024 | 5,039 | 4,388 | 3,884 | 3,892 |
Total Debt
|
|||
| 3,802 | 4,279 | 4,398 | 4,049 | 2,971 | 3,045 | 3,807 | 3,304 | 3,210 | 2,939 |
Net Debt
|
|||
| (727) | (751) | (865) | (1,495) | (661) | (1,517) | (2,205) | (1,626) | (1,383) | (1,279) |
Sh' Equity
|
|||
| 13.90% | 12.05% | 7.93% | (4.02%) | 7.78% | 15.15% | 13.89% | 16.03% | 15.44% | 13.06% |
ROA
|
|||
| 40.71% | 30.61% | 21.88% | 25.45% | 43.40% | 82.17% | 53.68% | 47.86% | 43.31% | 42.39% |
ROIC
|
|||
| (235.13%) | (133.02%) | (79.70%) | 31.02% | (78.29%) | (122.41%) | (42.99%) | (45.84%) | (53.04%) | (48.76%) |
ROE
|
|||
Bath & Body Works, Inc. peers in Specialty Retail
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ASO Academy Sports and Outdoors, Inc. | $3.0B | 8.0× | Compare |
| MNSO MINISO Group Holding Limited Unsponsored ADR | $2.6B | 14.9× | Compare |
| RH RH | $2.3B | 21.0× | Compare |
| SBH Sally Beauty Holdings, Inc. | $1.6B | 8.6× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| SVV Savers Value Village, Inc. | $1.4B | 58.4× | Compare |
| ARHS Arhaus, Inc. | $1.3B | 19.6× | Compare |
| EYE National Vision Holdings, Inc. | $1.3B | 26.2× | Compare |
| MUSA Murphy USA Inc. | $9.5B | 15.4× | Compare |
Bath & Body Works, Inc. (BBWI) key facts
- Bath & Body Works, Inc. (BBWI) is a Specialty Retail company in the Consumer Cyclical sector, listed on the New York Stock Exchange.
- Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.
- Net income was $649.0 million, or $3.11 per share (basic), a net margin of 8.90%.
- As of September 25, 2026, BBWI traded at $16.45, a market capitalization of $3.4 billion.
- At that price the stock trades at 4.3× trailing-twelve-month earnings and 0.5× sales.
- Bath & Body Works, Inc. pays an annual dividend of $0.80 per share, a yield of 1.84%, with a payout ratio of 26.5%.
- Return on equity was −48.8% and debt-to-equity -3.43.
Bath & Body Works, Inc. (BBWI) Latest News
25 Sep
Bath & Body Works reported a strong Q2 FY2026 beat with adjusted EPS of $0.62 (up 67.6% YoY) on net sales of $1.514B, down 2.3% but above consensus. Tariff refunds of about $80M boosted margins, while direct-to-consumer and international growth supported results. U.S./Canada store sales fell 5.4% to $1.13B; direct sales rose 3% to $275M; international sales jumped 24.9% to $108M. Gross profit rose 8.1% to $692M, margin 45.7% aided by refunds; ex-refund margin ~40.4%. SG&A flat at $467M; adjusted op. income up 30.4% to $225M (margin 14.8%). Cash, inventories, and debt improved; year-to-date cash flow stronger. Q3 guidance calls for sales down 5%-2.5% and EPS of 7-12c (GAAP 5-10c). Full-year outlook raised: net sales down 4%-2.5%; adjusted EPS $2.60-$2.80; GAAP $3.13-$3.33; FCF ~ $650M; capex ~$240M. Shares down ~9.9% since last report; consensus estimate revisions moved sharply lower. Widespread downward revisions to estimates despite a quarterly beat and raised full-year outlook indicate meaningful investor sentiment risk and a potentially slower near-term trajectory.
10 Sep
Bath & Body Works shares rise in extended trading after Barington Capital urges the company to explore a sale. Activist demand for a sale signals potential acquisition or major strategic overhaul that can significantly shift company trajectory and investor sentiment.
28 Aug
Bath & Body Works returned to digital growth yet projects overall sales decline, leaving uncertainty whether e-commerce gains can offset persistently weak store traffic. Expected sales decline combined with partial digital recovery indicates moderate pressure on near-term performance without altering long-term trajectory.
Bath & Body Works launches Reserve Collection for home fragrance products. New product collection in core home fragrance category supports incremental sales and innovation positioning.
27 Aug
Bath & Body Works stock rose 7.5% after beating Q2 earnings expectations and raising its fiscal 2026 outlook. Earnings beat combined with raised 2026 guidance signals stronger financial results and positive investor sentiment for BBWI.
Bath & Body Works advances digital revamp and new distribution initiatives in Q2 while facing tariff pressures. Digital revamp and new distribution initiatives represent major strategic moves that could significantly alter trajectory despite tariff headwinds.
Bath & Body Works Q2 net sales decline due to weak underlying demand. Q2 sales drop signals demand weakness that may pressure near-term revenue and valuation.
Bath & Body Works e-commerce returns to growth. E-commerce growth resumption indicates potential revenue gains for Bath & Body Works.
26 Aug
Bath & Body Works Inc beat Q2 2026 earnings guidance and raised its outlook. Beating guidance and raising outlook signals stronger financial results with direct positive effects on stock valuation and future projections.
BBWI held its Q2 2027 earnings call, covering financial results, operations and forward outlook. Earnings call details directly shape near-term stock movement and valuation.
Bath & Body Works raised its earnings outlook after beating second-quarter estimates, driving shares higher. Earnings beat plus raised outlook signals stronger performance and lifts investor sentiment.
Bath & Body Works raised its full-year earnings outlook after second-quarter profits exceeded forecasts. Profit beat combined with raised full-year guidance points to stronger future financial results and positive market reaction.
Bath & Body Works raised its annual outlook after beating Q2 profit forecasts. Profit beat combined with raised annual guidance signals stronger financial results and improved market positioning.
Bath & Body Works Q2 earnings key metrics detail revenue, margins and comparable sales trends that shape views on retail performance and outlook. Q2 earnings metrics supply financial data that can shift near-term investor sentiment and valuation without altering long-term strategy.
Bath & Body Works, Inc. held its Q2 2027 earnings call, covering financial results, operational updates and forward guidance for the company. Quarterly earnings data typically offers moderate insight into performance and outlook without signaling major strategic shifts.
Bath & Body Works shares rise sharply after the company posts stronger-than-expected quarterly sales and raises full-year guidance, reflecting improved store traffic and online demand. Better sales and raised guidance can moderately lift near-term financial results and sentiment without reshaping long-term strategy.
Bath & Body Works beat Q2 Wall Street sales estimates yet continues facing insufficient consumer store traffic. Q2 sales beat signals short-term resilience while ongoing traffic shortfalls point to sustained pressure on future revenue growth.
Bath & Body Works stock climbs after beating earnings expectations, though forward guidance is mixed. Earnings beat supports near-term stock gains while mixed guidance caps broader trajectory shifts.
Bath & Body Works Q2 earnings call highlighted comparable sales trends, gross margin expansion, and updated full-year guidance amid ongoing consumer spending caution. Q2 earnings call updates on sales, margins, and guidance can moderately shift near-term investor sentiment and valuation.
Bath & Body Works raised its profit outlook for Q2 2026 but reported weak sales. Mixed earnings signals with higher profit guidance offset by weak sales point to moderate effects on near-term investor views and operations.
Bath & Body Works beat earnings expectations but forecasts lower third-quarter earnings. Earnings beat offers short-term positive signal while lower third-quarter guidance introduces caution on near-term results.
Bath & Body Works (BBWI) posted Q2 earnings and revenues that exceeded analyst estimates. Q2 earnings and revenue beats deliver a positive but limited short-term lift to stock performance.
Bath & Body Works CEO states 2026 remains an investment year focused on long-term growth initiatives rather than immediate returns. CEO guidance labeling 2026 as investment year directly shapes earnings expectations and capital allocation outlook for the retailer.
Bath and Body Works beat Q2 CY2026 expectations but issued disappointing Q3 guidance. Mixed quarterly results with an earnings beat offset by weak forward guidance typically drive moderate short-term stock volatility.
Bath & Body Works reported second quarter results exceeding guidance along with continued progress on its transformation. Earnings beat and transformation updates point to noticeable but not transformative effects on financials and positioning.
24 Aug
BBWI set to report quarterly earnings with focus on comparable sales, margins, EPS and forward guidance amid ongoing retail sector pressures. Earnings data and guidance directly shape near-term stock trajectory and valuation for BBWI.
Bath & Body Works launches the Reserve Collection as a new home fragrance franchise. New fragrance franchise represents product innovation with moderate potential to influence sales and positioning.
18 Aug
Bath & Body Works pursues dividend payouts alongside Disney partnerships to strengthen brand moat and competitive positioning. Dividends combined with Disney deals represent major strategic moves capable of shifting brand trajectory and investor views.
Bath & Body Works shares rose after Citi upgraded the stock to Buy. Citi Buy upgrade triggered share price gains but represents limited fundamental change.
4 Aug
Bath & Body Works (BBWI) may beat earnings estimates in its next report, extending a pattern of positive surprises that could shape near-term investor sentiment and stock movement. Earnings preview questions create short-term sentiment shifts but lack major strategic or operational changes.